Quadrant Private Wealth Management’s AstraZeneca AZN Stock Holding History

Quadrant Private Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Buy	1,224 +4	+0.3%	+$752	0.05%	152
2026 Q1	$241K	Buy	+1,220	New	+$235K	0.04%	254

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Quadrant Private Wealth Management's AZN Position: Q2 2026 in Review

Quadrant Private Wealth Management increased its AstraZeneca (AZN) stake by 0.33% in Q2 2026, buying an estimated $752 and bringing the position to 1,224 shares worth $232K. The position accounts for 0.05% of the portfolio, ranked #152.

Quadrant Private Wealth Management first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $241K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Quadrant Private Wealth Management held 1,224 shares of AstraZeneca worth $232K as of Q2 2026.
Quadrant Private Wealth Management bought 4 AstraZeneca shares in Q2 2026, an estimated $752.
AstraZeneca made up 0.05% of Quadrant Private Wealth Management's portfolio in Q2 2026, its #152 holding.
Quadrant Private Wealth Management first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
Quadrant Private Wealth Management's AstraZeneca position peaked at $241K in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Quadrant Private Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.